SCHEMBL44995

SCHEMBL44995

NC(=O)c1ccncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8582840 1.00 NAPRT (0.59)
Arsenic SCHEMBL27830690 0.97 CYP17A1 (0.57)
Hydrochloric Acid SCHEMBL28802361 0.97 CYP17A1 (0.57)
Water SCHEMBL31094001 0.97 CYP17A1 (0.57)
Hydrochloric Acid SCHEMBL5710616 0.97 CYP17A1 (0.57)
SCHEMBL28382890 0.97 CYP17A1 (0.57)
SCHEMBL27649799 0.97
Hydrochloric Acid SCHEMBL1666770 0.97 CYP17A1 (0.57)
Carbamic Acid SCHEMBL29194228 0.95 NAPRT (0.61)
Formaldehyde SCHEMBL29045130 0.95 CYP17A1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8500 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106917-A1 EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL BioPhysics Pharma, Inc. (US) 2026-05-21 WO claimed
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP claimed
US-12605345-B2 Transdermal drug delivery system BioPhysics Pharma, Inc. (US) 2026-04-21 US claimed
US-20260069522-A1 SKIN DEPIGMENTATION COMPOSITION AND USE THEREOF KASRAEE BEHROOZ (CH) 2026-03-12 US claimed
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus MERCK SHARP & DOHME LLC 2026-03-03 US claimed
CN-121575215-A Amino acid-amide-saccharide composite leaching agent and application thereof 华碳科技(扬州)有限公司 2026-02-27 CN claimed
EP-4698227-A1 SUPRAMOLECULAR ASSEMBLIES, COMPOSITIONS COMPRISING THE SAME AND METHODS FOR PRODUCING THE SAME ELC Management LLC (US) 2026-02-25 EP claimed
EP-3623372-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH INC (US) 2026-02-04 EP claimed
EP-3606525-B1 COMPOSITIONS FOR TREATING AGING-ASSOCIATED IMPAIRMENTS USING CCR3-INHIBITORS ALKAHEST INC (US) 2025-12-10 EP claimed
US-12492193-B2 Pyrazole derivatives for the treatment of cystic fibrosis FONDAZIONE INSTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-12-09 US claimed
EP-0021176-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1981-01-07 EP claimed
US-4217450-A ANTIBIOTICS, BACTERICIDES AJINOMOTO COMPANY, INCORPORATED (JP) 1980-08-12 US claimed
US-4150223-A ANTIBIOTICS MERCK & CO., INC. (US) 1979-04-17 US claimed
US-4148997-A 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1979-04-10 US claimed
EP-0000393-A1 Beta-lactam compounds, process for their preparation and their use BAYER AG (DE) 1979-01-24 EP claimed
US-4132789-A 7-[2-(2-Imino-4-thiazolin-4-yl)-2-sulfoacetamido]cephalosporins and antibacterial compositions containing them TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1979-01-02 US claimed
US-4120958-A ANALGESICS, ANTIPYRETICS, ANTIRHEUMATIC INTERX RESEARCH CORPORATION (US) 1978-10-17 US claimed
US-4032521-A ANTIBIOTICS MERCK & CO., INC. (US) 1977-06-28 US claimed
US-4025622-A ANTIBACTERIAL Ogura, Haruo (JA) 1977-05-24 US claimed
US-3957804-A NICKEL AND IRON OXIDE HYDRATION CATALYSTS SHOWA DENKO KABUSHIKI KAISHA (JA) 1976-05-18 US claimed